Customer Publication

SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD

Authors: D. Wang et al.

Journal: Clinical and Translational Medicine (2020)

Institution: Shengjing Hospital of China Medical University

Research Areas: Cancer research

Cell Lines: U251, U373 (U251 - human glioblastoma astrocytoma, U373 - human glioblastoma astrocytoma)

Summary: 40 % of primary intracranial tumors are glioma and is the most common primary tumor. Additionally, it is hard to treat as it is invasive and prone to recurrence. Thus in this paper, D. Wang with colleagues have studied what is the role of SUMOylation, expression, and interaction in vasculogenic mimicry, which is a blood supply channel in glioma. Authors have shown that UBE21/PUM2/CEBPD/DSG2 gene expression plays a crucial role in regulating glioma vasculogenic mimicry. In this study, HoloMonitor M4 was used to study glioma cell migration capacity after transfection.

Keywords: HoloMonitor M4, cell movements, CEBPD, PUM, SUMOylation, UBEI, vasculogenic mimicry

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2